Letter

Safer non-cardiac surgery for patients with coronary artery disease

BMJ 1999; 319 doi: 10.1136/bmj.319.7205.320 (Published 31 July 1999)
Cite this as: BMJ 1999;319:320

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Preoperative aspirin does increase risk of perioperative bleeding

  1. M S Avidan, Clinical lecturer in anaesthesia,
  2. B J Hunt, Consultant (Beverley.hunt@gstt.sthames.nhs.uk)
  1. United Medical and Dental Schools, Guy's, King's College and St Thomas's Hospitals' Medical and Dental School, St Thomas's Hospital, London SE1 7EH
  2. Department of Haematology and Rheumatology, St Thomas's Hospital
  3. Sir Humphry Davy Department of Anaesthesia, Bristol Royal Infirmary, Bristol BS2 8HW
  4. Russells Hall Hospital, Dudley DY1 2HQ
  5. Birmingham Clinical Trials Unit, Medical School, University of Birmingham, Birmingham B15 2TH
  6. University of Birmingham Department of Anaesthesia and Intensive Care, Queen Elizabeth Hospital, Birmingham B15 2TH

    EDITOR—In Sonksen et al's editorial on safer non-cardiac surgery for patients with coronary artery disease the authors say that they considered that aspirin does not increase perioperative bleeding.1 We were astonished to read this. They based the statement on studies of aspirin's mechanism of action in vitro and the preoperative use of the bleeding time.

    The bleeding time correlates poorly with other tests of platelet function and is a poor predictor of bleeding.2 The editorial states that aspirin has no effect on platelet aggregation induced by thrombin and high dose collagen. This statement is based only on a study that used flow cytometry. In other studies, laboratory tests of platelet function have shown impaired platelet activity induced by collagen and thrombin after aspirin.3 4 Impaired platelet function in vitro has been documented for more than 72 hours after ingestion of aspirin.

    In vitro studies are not predictive of in vivo behaviour, and several clinical studies have clearly shown that aspirin does increase bleeding in both cardiac and non-cardiac surgery.3 5 For prostate surgery the withdrawal of aspirin for at least a week preoperatively …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular